Do phosphodiesterase type 5 inhibitors protect against condom-associated erection loss and condom slippage?


Sanders, Stephanie A., Milhausen, Robin R., Crosby, Richard A., Graham, Cynthia A. and Yarber, William L. (2009) Do phosphodiesterase type 5 inhibitors protect against condom-associated erection loss and condom slippage? Journal of Sexual Medicine, 6, (5), 1451-1456. (doi:10.1111/j.1743-6109.2009.01267.x).

Download

[img] PDF - Accepted Manuscript
Restricted to Repository staff only

Download (180Kb) | Request a copy

Description/Abstract

Introduction.  Some physicians prescribe phosphodiesterase type 5 inhibitors (PDE5i) for men who experience condom-associated erection difficulties with a view to increasing condom use and reducing risk of sexually transmitted infections.

Aim.  To examine whether the prevalence of erection-related condom problems differs between men using and not using PDE5i at the last condom-protected penile–vaginal (PVI) or penile–anal intercourse.

Methods.  Seven hundred-five men who had used a male condom during the past 3 months for PVI were selected from a sample recruited through advertisement to an electronic mailing list for a large, internet-based, sexual-enhancement product company. An internet-based questionnaire posted in 2006 assessed condom-use errors and problems.

Main Outcome Measures.  Men who did and did not use PDE5i during the last time a condom was used were compared on: (i) erection loss while applying a condom; (ii) erection loss during sex while using a condom; (iii) condom slipped off during sex; (iv) delayed condom application (penetration of the vagina or anus prior to application of the male condom); (v) early condom removal (condom taken off and intercourse continued without it); (vi) “problem with the way the condom fit”; (vii) “problem with the way the condom felt”; and (viii) condom breakage.

Results.  Controlling for age, marital status (yes/no), and having children (yes/no), PDE5i users, compared with nonusers, were: (i) three times more likely to report erection loss during sex while using a condom (adjusted odds ratio [AOR] = 3.21, 95% confidence interval [CI] = 1.40–7.39, P = 0.006); (ii) almost five times more likely to report the condom slipped off during sex (AOR = 4.75, 95% CI = 1.68–13.44, P = 0.003); and (iii) more than twice as likely to remove condoms before sex was over (AOR = 2.46, 95% CI = 1.09–5.56, P = 0.03).

Conclusions.  Physicians prescribing PDE5i may want to evaluate whether men are experiencing condom-associated erection difficulties and, if they are, consider titrating dosages and/or making referrals for psychosexual therapy and/or condom skills education.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1111/j.1743-6109.2009.01267.x
ISSNs: 1743-6095 (print)
1743-6109 (electronic)
Subjects: B Philosophy. Psychology. Religion > BF Psychology
R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions: Faculty of Social and Human Sciences > Psychology
ePrint ID: 206731
Date Deposited: 10 Jan 2012 17:12
Last Modified: 02 Jan 2016 12:43
URI: http://eprints.soton.ac.uk/id/eprint/206731

Actions (login required)

View Item View Item

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics